APC and colorectal carcinoma: A genome-scale analysis has recognized that 90% of patients with CRC carried genetic variations in the Wnt signaling pathway, particularly the loss-of-functional variations of adenomatous polyposis coli (APC) and variations that activate the mutations of β-catenin [14].